MIRA Pharmaceuticals, Inc. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
MIRA Pharmaceuticals, Inc. (MIRA) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $3.57 million as of 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2024-11-12
- 2024-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $3.57M.
- 2024-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $2.22M.
- 2024-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $3.16M.
- 2023-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $4.37M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest as first filed |
|---|---|---|
| 2024-09-30 | $3.57M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $2.22M 10-Q · filed 2024-11-12 | |
| 2024-03-31 | $3.16M 10-Q/A · filed 2024-08-16 | |
| 2023-12-31 | $4.37M 10-Q · filed 2024-11-12 | |
| 2023-09-30 | $8.12M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $1.20M 10-Q · filed 2024-11-12 | |
| 2023-03-31 | -$1.79M 10-Q/A · filed 2024-08-16 | -$1.79M 10-Q · filed 2023-09-15 |
| 2022-12-31 | -$596.23K 10-Q · filed 2024-11-12 | |
| 2022-09-30 | $320.45K 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $1.08M 10-Q · filed 2023-11-13 | |
| 2022-03-31 | $2.37M 10-Q · filed 2023-11-13 | |
| 2021-12-31 | $2.26M 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |